Generalized Anxiety and Seroquel

Stopped early · Not applicable

Conditions studied: Generalized Anxiety Disorder, Seroquel XR

In brief

The 12 week clinical trial of Seroquel in Generalized Anxiety Disorder (GAD) patients will be combined with fMRI experiments.

Key facts

Study ID

NCT01066143

Run by

Mclean Hospital

People needed

8

Starts

2010-02-01

Expected to finish

2013-02-01

Last updated by the study team

2017-05-17

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Provision of written informed consent
• Fluency in English
• A diagnosis of GAD
• No pregnancy
• Right-handedness
• Psychotropic medication-free at the start of the study

You may not qualify if…

• Pregnancy or lactation
• Any current DSM-IV-TR Axis I disorder
• Any mental retardation or cognitive impairment that precludes informed consent
• Known intolerance or lack of response to quetiapine fumarate
• Substance or alcohol dependence at enrollment
• Participation in another drug trial within 4 weeks prior enrollment
• History of allergic reaction or hypersensitivity to Seroquel or Seroquel XR
• History of prior Seroquel or other antipsychotic agents use
• Contraindications to magnetic resonance imaging
• Treatment with an effective medication for GAD

Where it is running

• McLean Hospital — Belmont, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.